Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 22, 2025Disease and DiagnosisOpen Access

Evaluation of Liver Fibrosis Using Non-invasive Indices in the Bandar Kong Cohort Population, Hormozgan-Iran, During 2016–2018

View Full Paper
Ask AI
Bookmark
Share

Authors

MRM. RazmpourMRM. RazmpourPPPooriya Pakdaman

Discussion

Loading...

Member takes

Overview

Observational analysis examines liver fibrosis indicators in 3,886 patients, suggesting diabetes heightens risk factors.

Key Points

  • Advanced fibrosis prevalence assessed via non-invasive indices revealed significant risk factors, including diabetes.
  • Based on the FIB-4, APRI, Forns, and BARD indices, 67.4% reported advanced fibrosis, underscoring the disease's severity.
  • Observational study involving 3,886 individuals collected demographic data, emphasizing the necessity of early diagnosis and risk assessment.
  • Identifying independent risk factors like age, BMI, and gender is crucial for improving strategies to combat liver fibrosis.

Cite This Study

Razmpour et al. (2025) studied this question.

synapsesocial.com/papers/68af33e9cf1dd9ea359e93a4https://doi.org/10.34172/ddj.1657
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation of Demography, Liver Function Tests, and Lipid Profile with Fibroscan Results in Patients with Nonalcoholic Fatty Liver Disease Attending a Tertiary Care Hospital in West Bengal2025
  2. 2Diagnostic Performance of Fibrosis‐4 Index, Nonalcoholic Fatty Liver Disease Fibrosis Score, <scp>AST</scp>‐To‐Platelet Ratio Index, and <scp>BARD</scp> Score Among Young and Older Adults for the Diagnosis of Advanced <scp>MASLD</scp> Fibrosis: A Retrospective Cohort Study2025 · 5 citations
  3. 3Non-invasive fibrosis tools lack clinical utility for identifying advanced fibrosis in Fontan-associated liver disease: a retrospective cohort study2025 · 3 citations
  4. 4Blood Biomarkers of Fibrosis as Alternatives to FibroScan2025
  5. 5Evaluation of Platelet Parameters in Relation to Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Scores among Non-alcoholic Fatty Liver Disease Patients and Healthy Controls: An Exploratory Study2025